This discrepancy is particularly evident among individuals with personal or family experiences with cancer: for instance, men with a family history of prostate cancer may favor PSA screening despite the risks of overdiagnosis, prioritizing peace of mind over clinical probabilities [2, 13]. Here, KLK3 is linked to prostate carcinoma.